İskemik Kalp Hastalığı, Kalp Yetersizliği ve Kanıta Dayalı Tedavi Bakım Uygulamaları
Özet
Kronik böbrek hastalığı nedeniyle hemodiyaliz tedavisi alan bireylerde iskemik kalp hastalığı ve kalp yetersizliği oldukça yaygın görülmekte olup bu durum, hastalarda morbidite ve mortalite oranlarını önemli ölçüde artırmaktadır. Bu nedenle hemodiyaliz hastalarına bakım veren sağlık profesyonellerinin, bu kardiyovasküler komplikasyonların hazırlayıcı faktörlerini, patofizyolojik süreçlerini, klinik belirtilerini, tedavi yaklaşımlarını ve izlem basamaklarını ayrıntılı olarak bilmeleri büyük önem taşır. Vasküler kalsifikasyon, sıvı yüklenmesi, anemi, elektrolit dengesizlikleri ve kronik inflamasyon gibi mekanizmaların iyi anlaşılması, erken uyarı işaretlerinin tanınmasına ve zamanında müdahale edilmesine olanak sağlar. Etkili hemşirelik bakımı; kardiyovasküler durumun düzenli izlenmesini, eşlik eden hastalıkların yönetimini, tedaviye uyumun desteklenmesini ve hastaların semptom kontrolü ile yaşam tarzı değişiklikleri konusunda bilinçlendirilmesini içerir. Erken tanı ve multidisipliner yaklaşım, bu sekonder hastalıkların ilerlemesini yavaşlatabilir ve hastaların yaşam kalitesini artırabilir. Bu nedenle sağlık profesyonellerinin kanıta dayalı bilgilerle donatılması ve gerekli klinik yetkinliklere sahip olması, hemodiyaliz hastalarında kardiyovasküler risklerin azaltılması açısından kritik öneme sahiptir.
Referanslar
Varian FL, Parker WAE, Fotheringham J, et al. Treatment Inequity in Antiplatelet Therapy for Ischaemic Heart Disease in Patients with Advanced Chronic Kidney Disease: Releasing the Evidence Vacuum. Platelets. 2023;34(1). doi: 10.1080/09537104.2022.2154330.
Farah Yusuf Mohamud M, Nur Adan F, Osman Omar Jeele M, et al. Major Cardiovascular Events and Associated Factors among Routine Hemodialysis Patients with End-Stage Renal Disease at Tertiary Care Hospital in Somalia. Frontiers in Medicine (Lausanne). 2023;19;10:1086359. doi: 10.3389/fmed.2023.1086359..
Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of Haemodialysis Outcomes. Nature Reviews Nephrology. 2022; 18(6):378-395. doi: 10.1038/s41581-022-00542-7.
Ateş K, Seyahi N, Koçyiğit İ. Türkiye 2022 Yılı Ulusal Nefroloji, Diyaliz ve Transplantasyon Kayıt Sistemi Raporu. Türkiye Nefroloji Derneği. 2023 Kasım; s. 1–196.
Echefu G, Stowe I, Burka S, et al. Pathophysiological Concepts and Screening of Cardiovascular Disease in Dialysis Patients. Frontiers in Nephrology. 2023;3:1198560. doi: 10.3389/fneph.2023.1198560.
Tang W, Zhang Y, Wang Z, et al. Development and Validation of a Multivariate Model for Predicting Heart Failure Hospitalization and Mortality in Patients Receiving Maintenance Hemodialysis. Renal Failure. 2023;45(2):2255686. doi: 10.1080/0886022X.2023.2255686.
Zoccali C, Mallamaci F, Adamczak M, et al. Cardiovascular Complications in Chronic Kidney Disease: A Review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovascular Research. 2023;119(11):2017–2032. doi: 10.1093/cvr/cvad083.
Okabe H, Muraoka Y, Naka Y, et al. Malnutrition Leads to the Progression of Coronary Artery Calcification in Hemodialysis Patients. PLoS One. 2023;18(1):e0280383. doi: 10.1371/journal.pone.0280383.
Ebert T, Barany P. Lifelong Statins for Long Life in Dialysis Patients? Clinical Kidney Journal. 2023;16(10):1541-1542.
Chen KT, Kang YN, Lin YC, et al. Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis: A Systematic Review and Meta-Analysis. Clinical Journal of the American Society of Nephrology. 2021; 16(6):916-925. doi: 10.2215/CJN.15841020.
Lin L, Teng J, Shi Y, et al. Lipoprotein-Associated Phospholipase A2 Predicts Cardiovascular Death in Patients on Maintenance Hemodialysis: A 7-Year Prospective Cohort Study. Lipids in Health and Disease. 2024;23(1):15. doi: 10.1186/s12944-023-01991-0.
Ding H, Zhu J, Tian Y, et al. Relationship between the Triglyceride-Glucose Index and Coronary Artery Calcification in Asymptomatic, Non-Diabetic Patients Undergoing Maintenance Hemodialysis. Renal Failure. 2023;45(1):2200849.
Haroon SWP, Tai BC, Ling LH, Teo L, Davenport A, Schurgers L, et al. Treatment to Reduce Vascular Calcification in Hemodialysis Patients Using Vitamin K (Trevasc-HDK): A Study Protocol for A Randomized Controlled Trial. Medicine. 2020;99(36):e21906.
Mudrik-Zohar H, Alon D, Nacasch N, et al. Neutrophil Reactive Oxygen Formation, Bacterial Infections and Mortality in Malnourished Hemodialysis Patients: Evaluation of Clinical Outcomes. Seminars in Dialysis. 2023;36(5):399-406.
Lewandowski E, Cinquegrani M. Coronary Heart Disease. In: Wing J, Schiffman F (Eds.), Cecil Essentials of Medicine. Philadelphia: Elsevier; 2022. p. 77–99.
Timofte D, Tanasescu MD, Balan DG, Tulin A, Stiru O, Vacaroiu IA, et al. Management of Acute Intradialytic Cardiovascular Complications: Updated Overview (Review). Experimental and Therapeutic Medicine. 2021;21(3):282.
Levi A, Simard T, Glover C. Coronary Artery Disease in Patients with End-Stage Kidney Disease; Current Perspective and Gaps of Knowledge. Seminars in Dialysis. 2020;33(3):187-197.
O’Lone E, Apple FS, Burton JO, et al. Defining Myocardial Infarction in Trials of People Receiving Hemodialysis: Consensus Report from the SONG-HD MI Expert Working Group. Kidney International. 2023;103(6):1028-1037.
Ikizler TA, Burgner AM, Concepcion BP. Chronic Kidney Disease. In: Wing J, Schiffman J (Eds.), Andreoli and Carpenter’s Cecil Essentials of Medicine.Philadelphia: Elsevier, Inc.;2022.p.334-341.
Burlacu A, Genovesi S, Basile C, et al. Coronary Artery Disease in Dialysis Patients: Evidence Synthesis, Controversies and Proposed Management Strategies. Journal of Nephrology. 2021;34(1):39-51.
Zhao K, Shen B, Wei H, et al. Diagnostic Value of High Sensitivity Cardiac Troponin T (hs-cTnT) in Dialysis Patients with Myocardial Infarction. Frontiers in Cardiovascular Medicine. 2023;10:1278073. doi: 10.3389/fcvm.2023.
Kampmann J, Heaf J, Mogensen CB, et al. Troponin Cut-Offs for Acute Myocardial Infarction in Patients with Impaired Renal Function: A Systematic Review and Meta-Analysis. Diagnostics. 2022;12(2):276. doi: 10.3390/diagnostics12020276.
Huang Y, Ge Y, Li F, et al. Elucidating the Relationship between Nutrition Indices and Coronary Artery Calcification in Patients Undergoing Maintenance Hemodialysis. Therapeutic Apheresis and Dialysis. 2022;26(1):71-84. doi: 10.1111/1744-9987.13693.
Poli FE, Gulsin GS, McCann GP, et al. The Assessment of Coronary Artery Disease in Patients with End-Stage Renal Disease. Clinical Kidney Journal. 2019;12(5):721-734. doi: 10.1093/ckj/sfz088.
Koh SJQ, Yap J, Jiang Y, et al. Clinical Outcomes in End-Stage Renal Disease on Dialysis and Severe Coronary Artery Disease: A Real-World Study. International Journal of Cardiology. 2023;378:105-110. doi: 10.1016/j.ijcard.2023.02.029.
Murdeshwar HN, Anjum F. Hemodialysis. In: StatPearls [İnternet]. Treasure Island (FL): StatPearls Publishing; 2024. (19/09/2024 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK499961/ adresinden erişilmiştir.
Liu YW, Hsu YT, Lee WC, et al. Review of Traditional Chinese Medicines for Common Complications Related to Hemodialysis: An Evidence-Based Perspective. Evidence-Based Complementary and Alternative Medicine. 2021;2021:9953986.
Palmer SC, Di Micco L, Razavian M, et al. Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons with Chronic Kidney Disease. Annals of Internal Medicine. 2012 ;156(6):445-59.
James S, Budaj A, Aylward P, et al. Ticagrelor versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function. Circulation. 2010;122(11):1056-1067.
Ye Z, Wang Q, Ullah I, et al. Impact of Hemodialysis on Efficacies of the Antiplatelet Agents in Coronary Artery Disease Patients Complicated with End-Stage Renal Disease. Journal of Thrombosis and Thrombolysis. 2024;57(4):558-565.
Sung FC, Jong YC, Muo CH, et al. Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan. Frontiers in Pharmacology. 2022;13:815882.
Mahmoudi Z, Roumi Z, Askarpour SA, et al. The Effects of Omega-3 Fatty Acids Supplementation on Hemoglobin, Hematocrit, and Platelet Levels of Patients with ESRD Condition Undergoing Dialysis. Journal of Translational Autoimmunity. 2024;8:100233.
Tasoudis PT, Varvoglis DN, Tzoumas A, et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery in dialysis‐dependent patients: A pooled meta‐analysis of reconstructed time‐to‐event data. Journal of Cardiac Surgery. 2022;37(10):3365–3373.
Huang M, Lv A, Wang J, et al. Exercise Training and Outcomes in Hemodialysis Patients: Systematic Review and Meta-Analysis. American Journal of Nephrology. 2019;50(4):240–254.
Pu J, Jiang Z, Wu W, et al. Efficacy and Safety of Intradialytic Exercise in Haemodialysis Patients: A Systematic Review and Meta-Analysis. BMJ Open. 2019;9(1):e020633.
Matsuzawa R, Roshanravan B, Shimoda T, et al. Physical Activity Dose for Hemodialysis Patients: Where to Begin? Results from A Prospective Cohort Study. Journal of Renal Nutrition. 2018;28(1):45–53.
Luo J, Xu S, Li H, et al. Prognostic Impact of Stress Hyperglycemia Ratio in Acute Myocardial Infarction Patients with and without Diabetes Mellitus. Nutrition, Metabolism and Cardiovascular Diseases. 2022;32(10):2356–2366.
Xie E, Ye Z, Wu Y, et al. Predictive Value of the Stress Hyperglycemia Ratio in Dialysis Patients with Acute Coronary Syndrome: Insights from A Multi-center Observational Study. Cardiovascular Diabetology. 2023;22(1):288.
Liddell TS, Bassett R, Link DK. Hypertension Management in Patients with Chronic Kidney Disease. The Nurse Practitioner. 2019;44(12):34–40.
Kauric-Klein Z. Sodium Knowledge, Beliefs, and Behaviors in Patients on Chronic Hemodialysis. Blood Purification. 2020;49(1–2):25–32.
Liu Y, Zhou Y, Li X, et al. Influences of Trans-Theoretical Model-Based Diet Nursing Intervention on Sarcopenia and Quality of Life in Maintenance Hemodialysis Patients. Nutrición Hospitalaria. 2024;41(2):278-285.
Schrauben SJ, Apple BJ, Chang AR. Modifiable Lifestyle Behaviors and CKD Progression: A Narrative Review. Kidney360. 2022;3(4):752–778. doi: 10.34067/KID.0003122021.
Han BG, Lee JY, Choi SO, et al. Relative Overhydration is Independently Associated with Left Ventricular Hypertrophy in Dialysis Naïve Patients with Stage 5 Chronic Kidney Disease. Scientific Reports. 2020:10(1):15924.
Yang N, Yang K, Pan S, et al. Progress in the Application of the Neutrophil-to-Lymphocyte Ratio in Dialysis-Related Complications. Renal Failure. 2023;45(2):2259996.
Mark PB, Mangion K, Rankin AJ, Rutherford E, Lang NN, Petrie MC, et al. Left Ventricular Dysfunction with Preserved Ejection Fraction: The Most Common Left Ventricular Disorder in Chronic Kidney Disease Patients. Clinical Kidney Journal. 2022;15(12):2186–2199. doi: 10.1093/ckj/sfac146.
Yu X, Zhang D, Chen J, et al. Heart Failure with Preserved Ejection Fraction in Haemodialysis Patients: Prevalence, Diagnosis, Risk Factors, Prognosis. ESC Heart Failure. 2023;10(5):2816–2825.
Meena OP, Meghwal H, Meena R, et al. A Study on Correlation of Anemia with Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: A Cross Sectional Study from Southern Rajasthan. International Journal of Advances in Medicine. 2022;9(7):796-800. doi. 10.18203/2349-3933.ijam20221706.
Hothi DK. Managing Heart Failure in Dialysis Patients. Pediatric Nephrology. 2021;36(8):2531-2535.
Roehm B, Gulati G, Weiner DE. Heart Failure Management in Dialysis Patients: Many Treatment Options with No Clear Evidence. Seminars in Dialysis. 2020;33(3):198–208.
Guaricci AI, Sturda F, Russo R, et al. Assessment and Management of Heart Failure in Patients with Chronic Kidney Disease. Heart Failure Reviews. 2024;29(2):379–394.
Huang X mei, Li J jing, Yin W, Fu H ling, Yu F, Gu L qing, et al. Effect of Sacubitril Valsartan on Heart Failure with Mid-Range or Preserved Ejection Fraction in Patients on Maintenance Hemodialysis: Real-World Experience in A Single-Center, Prospective Study. BMC Cardiovascular Disorders. 2024;24(1):79.
Valga F, Monzon T, Vega-Diaz N, et al. Serum Chloride as A Marker of Cardiovascular and All-Cause Mortality in Chronic Hemodialysis Patients: 5-Year Follow-up Study. Nefrología (English Edition). 2023:43 Suppl 2:47-56.
Axelsson Raja A, Warming PE, Nielsen TL, et al. Left-Sided Heart Disease and Risk of Death in Patients with End-Stage Kidney Disease Receiving Haemodialysis: An Observational Study. BMC Nephrology. 2020;21(1):413. doi: 10.1186/s12882-020-02074-3.
Torino C, Mallamaci F, Sarafidis P, et al. The Long-Term Effect of A Lung Ultrasound Intervention on the Risk for Death, Heart Failure and Myocardial Infarction in Dialysis Patients. Nephrology Dialysis Transplantation. 2024;39(2):371–4.
Zoccali C, Torino C, Mallamaci F, et al. A Randomized Multicenter Trial on A Lung Ultrasound–Guided Treatment Strategy in Patients on Chronic Hemodialysis with High Cardiovascular Risk. Kidney International. 2021 Dec 1;100(6):1325–1333.
Kawasaki S, Sakai Y, Harasawa S, et al. The Efficacy and Safety of Ivabradine Hydrochloride in Hemodialysis Patients with Chronic Heart Failure. Therapeutic Apheresis and Dialysis. 2024;28(3):354-363. doi: 10.1111/1744-9987.14107.
Tan Z, Ke G, Huang J, et al. Effects of Carvedilol on Cardiovascular Events and Mortality in Hemodialysis Patients, A Systematic Review and Meta-Analysis. Iranian Journal of Kidney Diseases. 2020;14(4):256-266.
Zhou H, Sim JJ, Shi J, et al. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis. American Journal of Kidney Diseases. 2021;77(5):704–712.
Wu PH, Lin YT, Liu JS, et al. Comparative Effectiveness of Bisoprolol and Carvedilol among Patients Receiving Maintenance Hemodialysis. Clinical Kidney Journal. 2021;14(3):983–990.
Hundemer GL, Sood MM, Canney M. β-Blockers in Hemodialysis: Simple Questions, Complicated Answers. Clinical Kidney Journal. 2021;14(3):731–734.
Khan MS, Ahmed A, Greene SJ, et al. Managing Heart Failure in Patients on Dialysis: State of The Art Review. Journal of Cardiac Failure. 2023;29(1):87–107. doi: 10.1016/j.cardfail.2022.09.013.
El-Chami MF, Burke MC, Herre JM, et al. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study. Heart Rhythm. 2020;17(9):1566–1574.
Bağriaçik E, Dikmen BT. Self‐Management Training in Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Systematic Review. Seminars in Dialysis. 2024;37(2):91–100.
Zhang Y, Wu M, Mao C. Risk Factors and Their Association with Mortality in Patients Undergoing Long-Term Hemodialysis or/and Kidney Transplant Patients or Late-Stage Chronic Kidney Disease: A Single Center, Prospective Observational Study. Medicine (United States). 2024;103(1):E36805.
Middleton JP, Sun S, Murray S, et al. Randomized Trial of Patiromer on Efficacy to Reduce Episodic Hyperkalemia in Patients with ESKD Treated With Hemodialysis. Kidney International Reports. 2024;9(11):3218–3225.
Tsirigotis S, Polikandrioti M, Alikari V, et al. Factors Associated with Fatigue in Patients Undergoing Hemodialysis. Cureus. 2022;14(3):e22994.
Debnath S, Rueda R, Bansal S, et al. Fatigue Characteristics on Dialysis and Non-Dialysis Days in Patients with Chronic Kidney Failure on Maintenance Hemodialysis. BMC Nephrology. 2021;22(1):112. doi: 10.1186/s12882-021-02314-0.
Samuel Raj V V, Mangalvedhe P V, Shetty MS, et al. Impact of Exercise on Fatigue in Patients Undergoing Dialysis in a Tertiary Care Hospital. Cureus. 2023;15(2):e35004.
Perez-Dominguez B, Casana-Granell J, Garcia-Maset R, et al. Effects of Exercise Programs on Physical Function and Activity Levels in Patients Undergoing Hemodialysis: A Randomized Controlled Trial. European Journal of Physical and Rehabilitation Medicine. 2021;57(6):994-1001.
Hu H, Wu C, Kwok JYY, et al. Effects of Different Exercises on Physical Function, Dialysis Adequacy, and Health-Related Quality of Life in Maintenance Hemodialysis Patients: A Systematic Review and Network Meta-Analysis. American Journal of Nephrology. 2023;54(9–10):379–390.
Song Y, Chen L, Wang M, et al. The Optimal Exercise Modality and İntensity for Hemodialysis Patients Incorporating Bayesian Network Meta-Analysis and Systematic Review. Frontiers in Physiology. 2022;13:945465. doi: 10.3389/fphys.2022.945465.
Ng MSN, Wong CL, Ho EHS, Hui YH, Miaskowski C, So WKW. Burden of Living with Multiple Concurrent Symptoms in Patients with End‐Stage Renal Disease. Journal of Clinical Nursing. 2020;29(13–14):2589–2601. doi: 10.1111/jocn.15282.
Hajmohamadi M, Imani-Goghary Z, Jahani Y, et al. Investigating the Effectiveness of Self-Mmanagement Program Based on 5A Model on Fatigue and Dyspnea in Patients with Heart Failure. Bratislava Medical Journal. 2023;124(11):821–826.
